NCI Cancer Bulletin: A Trusted Source for Cancer Research NewsNCI Cancer Bulletin: A Trusted Source for Cancer Research News
June 29, 2004 • Volume 1 / Number 26 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

NCI Cancer Bulletin Archive

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document
  • View/Print PDF

The information and links on this page are no longer being updated and are provided for reference purposes only.

Notes

CCR Grand Rounds
July 6: Dr. Ronald E. Gress of NCI's Center for Cancer Research will present "The Interface of Cancer Immunotherapy and Chemotherapy."

July 13: NCI Director Dr. Andrew C. von Eschenbach will present "Progress toward Eliminating the Suffering and Death Due to Cancer."

CCR Grand Rounds are held 8:30 to 9:30 a.m. at the NIH campus in Bethesda, Md., in the Clinical Center's Lipsett Amphitheater.

BSA Meeting
The NCI Board of Scientific Advisors (BSA) met June 24-25 on the NIH campus in Bethesda, Md. BSA advises NCI's director on scientific program policy and the progress and future direction of NCI's extramural research programs. It also conducts concept review of extramural program initiatives. BSA's 35 members represent the fields of laboratory, clinical, and biometric research; clinical cancer treatment; cancer etiology, behavioral and population science, prevention, and control; and the advocacy community. Members also provide perspective on the scientific areas that influence the understanding of cancer and efforts to lessen its burden.

At the meeting, BSA members heard reports from the NCI director and various NCI offices. In addition, NCI staff presented information on a number of new and ongoing programs. The Board provided concept review for new and re-issued projects including assessment of tobacco products promoted to reduce harm, nanotechnology, and partnerships between minority institutions and cancer centers.

Watch for more coverage of the BSA meeting in an upcoming issue of the NCI Cancer Bulletin.

NCI Health Communications Interns Graduate
On June 24, Nelvis Castro, acting director of the NCI Office of Communications, bid farewell to NCI's graduating class of health communication interns. NCI's Health Communication Internship Program offers 6-month internships in health communications and science writing. The interns serve from January through June or July through December. Applications for internships beginning in January 2005 are due by September 15, 2004. For more information on the program and for application materials and eligibility requirements, go to http://internship.cancer.gov.

Translating Research Into Practice
Translating Research Into Practice (TRIP) will take place July 12-14 in Washington, D.C. This national conference will examine state-of-the-art practice and future directions for disseminating research findings to accelerate the implementation of evidence-based clinical practice and health policy. Dr. Mark Clanton, NCI deputy director of Cancer Care Delivery Systems, will deliver a keynote address. Other NCI-related sessions include "The Curious Contradiction of Colorectal Cancer Screening vs. PSA Testing" and "Evidence-Based Tobacco Cessation Interventions for Underserved Populations." TRIP is cosponsored by the Agency for Healthcare Research and Quality, NCI, and the Department of Veterans Affairs, with support from the Substance Abuse and Mental Health Services Administration, the National Institute of Mental Health, and the National Institute on Drug Abuse. For the conference agenda, registration, and hotel reservations, go to www.blsmeetings.net/TRIP2004.

Zoon Moves to NIAID from NCI
NCI's Dr. Kathryn Zoon has left NCI to join the National Institute of Allergy and Infectious Diseases, where she will serve as deputy director for Planning and Development. Dr. Zoon joined NCI's Center for Cancer Research Metabolism Branch in January 2003, where she served as principal deputy director and principal investigator. Prior to her tenure at NCI, Dr. Zoon served as director of the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research from 1992 to 2002.